Belmont Global Advisors, Inc. - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 131 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q2 2015. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.

Quarter-by-quarter ownership
Belmont Global Advisors, Inc. ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q3 2016$2,590,000
+77.0%
470,000
+22.1%
2.45%
+74.4%
Q2 2016$1,463,000
+32.5%
385,000
-3.8%
1.40%
+25.1%
Q1 2016$1,104,000
+36.6%
400,000
+180.7%
1.12%
+7.3%
Q4 2015$808,000
+103.5%
142,500
+90.0%
1.05%
+55.3%
Q3 2015$397,000
+32.3%
75,000
+107.2%
0.67%
+102.4%
Q2 2015$300,000
+29.9%
36,200
-27.6%
0.33%
+41.7%
Q1 2015$231,000
+312.5%
50,000
+150.0%
0.24%
+434.1%
Q3 2014$56,000
-93.9%
20,000
-91.1%
0.04%
-93.3%
Q2 2014$915,000
-31.0%
225,000
-10.0%
0.66%
-40.8%
Q1 2014$1,327,000
-5.7%
250,0000.0%1.12%
-1.8%
Q4 2013$1,407,000250,0001.14%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q2 2015
NameSharesValueWeighting ↓
Nantahala Capital Management 11,578,568$20,147,0000.82%
Virtus ETF Advisers LLC 441,461$768,0000.68%
Hikari Power Ltd 2,300,000$4,002,0000.44%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,403,149$2,441,0000.17%
KNOTT DAVID M 225,400$392,0000.15%
Clear Harbor Asset Management, LLC 277,110$482,0000.09%
Malaga Cove Capital, LLC 97,264$169,0000.09%
Lehman Financial Resources, Inc. 80,800$140,0000.07%
Cheyne Capital Management (UK) LLP 50,000$87,0000.06%
Ballew Advisors, Inc 26,200$46,0000.05%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders